SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Round Rock, TX.

TSS Inc

TSSI is trending amid renewed optimism driven by its primary partner Dell's increased AI server shipment guidance, which is fueling community discussion about a potential rebound for the specialized data center provider after its recent stock decline and calls for improved transparency from management.

SPDR Series Trust - State Street SPDR S&P 600 TM Small Cap Growth ETF

SPDR S&P 600 Small Cap Growth ETF

SLYG is trending amidst highly volatile daily swings, frequently leading small-cap rallies or lagging behind other market segments. Community discussion reflects mixed sentiment on its short-term prospects, even as many consider it a core long-term holding for small-cap growth exposure.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital Holdings is trending as Morgan Stanley's new "Underweight" rating and $8 price target fuel widespread discussion on its performance, particularly given its historical underperformance compared to Bitcoin and other miners. The community is sharply divided, with some anticipating a short squeeze and highlighting its Bitcoin holdings, while others voice strong skepticism over management's value creation and the stalled French acquisition.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic (LUNC) is drawing attention from its community as Kraken reportedly reversed its delisting and Binance continues its burn initiatives, with ongoing debates surrounding Do Kwon's sentencing and the potential for a broader ecosystem revival through new project development.

Wells Fargo & Co. is a diversified and community-based financial services company, which engages in the provision of banking, insurance, investments, mortgage, and consumer and commercial finance products and services. It operates through the following segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The Consumer Banking and Lending segment offers consumer and small business banking, home lending, credit cards, auto, and personal lending. The Commercial Banking segment provides banking and credit products across industry sectors and municipalities, secured lending and lease products, and treasury management. The Corporate and Investment Banking segment is composed of corporate banking, investment banking, treasury management, commercial real estate lending and servicing, and equity and fixed income solutions, as well as sales, trading, and research capabilities. The Wealth and Investment Management segment refers to personalized wealth management, brokerage, financial planning, lending, private banking, trust, and fiduciary products and services. The company was founded by Henry Wells and William G. Fargo on March 18, 1852 and is headquartered in San Francisco, CA.

Wells Fargo & Co.

Wells Fargo is trending due to its strong Q3 earnings beat and the lifting of its seven-year asset cap, which the community views as a significant catalyst unlocking substantial growth potential. Investors are actively discussing the bank's raised profitability targets and strategic expansion across lending and wealth management, questioning if this momentum will lead to a sustained rally.

BlackRock Institutional Trust Company N.A. - iShares Russell 1000 Growth ETF

iShares Russell 1000 Growth ETF

The iShares Russell 1000 Growth ETF ($IWF) is trending amid an ongoing debate about large-cap growth's leadership, with some observers noting persistent bullish momentum and new highs, while others point to signs of decelerating momentum and a potential rotation towards value.

SPDR Series Trust - State Street SPDR Portfolio S&P 500 Growth ETF

SPDR Portfolio S&P 500 Growth ETF

SPYG is trending due to notable swings in large-cap growth performance, often challenging or retreating against value and dividend funds, fueling community discussion about whether growth's strong momentum can continue amidst broader market rotations.

BlackRock Institutional Trust Company N.A. - iShares iBoxx USD Investment Grade Corporate Bond ETF

iShares iBoxx USD Investment Grade Corporate Bond ETF

The iShares iBoxx USD Investment Grade Corporate Bond ETF ($LQD) is trending as the market anticipates a surge in investment-grade corporate bond issuance, notably for AI buildouts, which is testing already tight credit spreads. Community discussions revolve around how this increase in corporate leverage and issuance will be digested by the market and its implications for broader fixed income stability.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as its three-year EMBARK data for Elevidys demonstrates sustained efficacy in slowing Duchenne muscular dystrophy progression, a key development that the community believes highlights the stock's significant undervaluation compared to its commercial revenue and pipeline potential. Investors are keenly watching for further pipeline updates and the stock's reaction to its pronounced short interest amidst this positive clinical news.

ProShares Trust - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

UCO is trending as market participants actively discuss escalating geopolitical tensions involving potential US military actions in Venezuela and ongoing threats around Iran, driving anticipation of significant crude oil supply disruptions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Beats Revenue Estimates

Agios Pharmaceuticals (AGIO) delivered earnings and revenue surprises of +6.25% and +94.14%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains?

Sutro Biopharma (STRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Roivant Sciences Ltd. (ROIV) Reports Q3 Loss, Misses Revenue Estimates

Montes Archimedes Acquisition (ROIV) delivered earnings and revenue surprises of +9.43% and -67.32%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives Consensus Recommendation of "Hold" from Analysts

Shares of TScan Therapeutics, Inc. (NASDAQ:TCRX - Get Free Report) have been assigned an average rating of "Hold" from the seven research firms that are covering the firm, MarketBeat.com reports. One...

TScan Therapeutics (NASDAQ:TCRX) Shares Up 1.8% - What's Next?

TScan Therapeutics (NASDAQ:TCRX) Shares Up 1.8% - Still a Buy...

TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives Average Recommendation of "Hold" from Brokerages

Shares of TScan Therapeutics, Inc. (NASDAQ:TCRX - Get Free Report) have been given an average recommendation of "Hold" by the seven analysts that are presently covering the company, Marketbeat.com...

TScan Therapeutics (NASDAQ:TCRX) Major Shareholder Acquires $67,950.00 in Stock

TScan Therapeutics, Inc. (NASDAQ:TCRX - Get Free Report) major shareholder Lynx1 Capital Management Lp bought 75,500 shares of the company's stock in a transaction dated Monday, December 22nd. The...

TScan Therapeutics (NASDAQ:TCRX) Major Shareholder Buys 75,500 Shares

TScan Therapeutics, Inc. (NASDAQ:TCRX - Get Free Report) major shareholder Lynx1 Capital Management Lp acquired 75,500 shares of TScan Therapeutics stock in a transaction that occurred on Monday...

TScan Therapeutics (NASDAQ:TCRX) Major Shareholder Lynx1 Capital Management Lp Acquires 80,069 Shares

TScan Therapeutics, Inc. (NASDAQ:TCRX - Get Free Report) major shareholder Lynx1 Capital Management Lp purchased 80,069 shares of the company's stock in a transaction that occurred on Friday...

Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines

Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines PR Newswire...

TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts. The company was founded by Christoph H. Westphal, Stephen Elledge, Lea Hachigian, and Tomasz Kula in 2018 and is headquartered in Boston, MA.

Tscan Therapeutics Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Current Price	$0.932
Prev Close	$0.9343
Open	$0.95
Dividend Yield	0.00%
50-Day Moving Average	$1.04
Beta	1.20
Avg. Volume	523,297.55
PE Ratio	-0.83

52-Week High	$2.57
52-Week Low	$0.8824
Market Capitalization	$52.89M
EPS (Annual)	-$1.14
Price to Book	0.37
Revenue Per Employee	$14,515.46

TCRX
Tscan Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TCRX News

TCRXTscan Therapeutics Inc